Melanoma Patient Network Europe sessions at ESMO 2016
Chemotherapy for melanoma - why is it not effective and what is its future?
The current status of chemotherapy for treating melanoma
Neoadjuvant therapy with trametinib and dabrafenib in high risk resectable BRAF-mutant melanoma
Rodabe N. Amaria
How can biomarkers help predict patient reponse in melanoma